Open AccessEfficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study
Author(s) -
P. Fioretto,
S. Del Prato,
J.B. Buse,
R. Goldenberg,
F. Giorgino,
D. Reyner,
A.M. Langkilde,
C.D. Sjöström,
P. Sartipy,
DERIVE Study Investigators
Publication year - 2018
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/jv9v-2w18
Subject(s) - dapagliflozin , medicine , type 2 diabetes , kidney disease , stage (stratigraphy) , diabetes mellitus , disease , urology , endocrinology , paleontology , biology